Dexamethasone
SIGMA/D1756 - ≥98% (HPLC), powder
Synonym: (11β,16α)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9α-Fluoro-16α-methyl-11β,17α,21-trihydroxy-1,4-pregnadiene-3,20-dione; 9α-Fluoro-16α-methylprednisolone; Prednisolone F
CAS Number: 50-02-2
Empirical Formula (Hill Notation): C22H29FO5
Molecular Weight: 392.46
EC Number: 200-003-9
MDL Number: MFCD00064136
Linear Formula: C22H29FO5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white |
| form | powder |
| InChI | 1S/C22H29FO5/c1-12-8-16-1 |
| InChI key | UREBDLICKHMUKA-CXSFZGCWSA |
| mp | 262-264 °C (lit.) |
| originator | Merck & Co., Inc., Kenilworth, NJ, U.S. |
| Quality Level | 200 ![]() |
| SMILES string | C[C@@H]1C[C@H]2[C@@H]3CCC |
| solubility | methanol: 25 mg/mL |
| storage temp. | 2-8°C |
| Application: | Dexamethasone has been used: • in culture media to induce differentiation of adipose-derived stem cells into osteogenic tissue • as a component of adipocyte differentiation medium • for in vitro stimulation of primary normal human bronchial epithelial cells (NHBE) and airway smooth muscle (ASM) |
| Biochem/physiol Actions: | Dexamethasone is known to be effective against relapsed multiple myeloma. It is found to decrease inflammation associated with cerebrospinal fluid and central nervous system (CNS) complications, such as hearing loss. |
| Biochem/physiol Actions: | Glucocorticoid anti-inflammatory agent |
| Biochem/physiol Actions: | Glucocorticoid anti-inflammatory agent. Regulates T cell survival, growth, and differentiation. Inhibits the induction of nitric oxide synthase. |
| Features and Benefits: | This compound is featured on the Nuclear Receptors (Steroids) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S. . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Dexamethasone is a potent glucocorticoid with minimal to no mineralocorticoid activity. Dexamethasone exhibits pleiotropic effects on multiple signaling pathways, some of its functions include, inhibition of neutrophil migration and reduction of lymphocyte colony proliferation. Research findings show, dexamethasone might prevent high-altitude pulmonary edema by decreasing pulmonary artery pressure. |
| Packaging: | 1, 5 g in glass bottle |
| Packaging: | 25, 100, 500 mg in glass bottle |
| Packaging: | Bottomless glass bottle. Contents are inside inserted fused cone. |
| Preparation Note: | Dexamethasone is soluble in DMSO (25 mg/ml), chloroform or ethanol. |
| Preparation Note: | Dilute 1 mg/ml stock solution 1:50 with sterile media and store frozen in working aliquots to avoid repeated freeze-thaw. |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H360FD |
| Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
| Hazard Codes | Xn |
| Risk Statements | 36/37/38-42/43 |
| Safety Statements | 22-26-36/37-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| mp | 262-264 °C (lit.) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51422306 |


